LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel: La doxycycline ou comment faire du neuf avec du vieux ?

Shehwaro, Nathalie / Langlois, Anne-Lyse / Gueutin, Victor / Gauthier, Marion / Casenave, Maud / Izzedine, Hassane

Therapie

2014  Band 69, Heft 2, Seite(n) 129–141

Abstract: Tetracyclines are broad-spectrum antibiotics that interfere with protein synthesis. They were first widely prescribed by dermatologists in the early 1950s in the treatment of acne. More recently, their biological actions on inflammation, proteolysis, ... ...

Titelübersetzung Doxycycline or how to create new with the old?.
Abstract Tetracyclines are broad-spectrum antibiotics that interfere with protein synthesis. They were first widely prescribed by dermatologists in the early 1950s in the treatment of acne. More recently, their biological actions on inflammation, proteolysis, angiogenesis, apoptosis, metal chelation, ionophoresis, and bone metabolism were studied. Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade components of the extracellular matrix (ECM). MMPs have direct or indirect effects on the vascular endothelium and the vascular relaxation/contraction system. The therapeutic effects of tetracyclines and analogues were studied in rosacea, bullous dermatoses, neutrophilic diseases, pyoderma gangrenosum, sarcoidosis, aortic aneurysms, cancer metastasis, periodontitis and autoimmune diseases autoimmune diseases such as rheumatoid arthritis and scleroderma. In addition, downregulation of MMP using doxycycline could be beneficial in reducing vascular dysfunction mediated by MMPs and progressive damage of the vascular wall. We review the nonantibiotic properties of doxycycline and its potential clinical applications.
Mesh-Begriff(e) Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents/therapeutic use ; Doxycycline/pharmacology ; Doxycycline/therapeutic use ; Drug Repositioning ; Humans ; Matrix Metalloproteinase Inhibitors/pharmacology ; Matrix Metalloproteinase Inhibitors/therapeutic use ; Matrix Metalloproteinases/metabolism ; Neoplasms/drug therapy ; Neoplasms/pathology ; Periodontal Diseases/drug therapy ; Rheumatic Diseases/drug therapy ; Skin Diseases/drug therapy
Chemische Substanzen Anti-Bacterial Agents ; Anti-Inflammatory Agents ; Matrix Metalloproteinase Inhibitors ; Matrix Metalloproteinases (EC 3.4.24.-) ; Doxycycline (N12000U13O)
Sprache Französisch
Erscheinungsdatum 2014-03
Erscheinungsland France
Dokumenttyp English Abstract ; Journal Article ; Review
ZDB-ID 603474-3
ISSN 1958-5578 ; 0040-5957
ISSN (online) 1958-5578
ISSN 0040-5957
DOI 10.2515/therapie/2013069
Signatur
Ue I Zs.272: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang